RAYMOND JAMES & ASSOCIATES – Vertex Pharmaceuticals Incorporated Transaction History
RAYMOND JAMES & ASSOCIATES portfolio value:
$105.31M
portfolio value
RAYMOND JAMES & ASSOCIATES quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.86% | 3.11K shares | 3.69M | $289.54 | 363.73K |
| Q2 2022 | share | Decrease | -13.60% | -56.78K shares | -7.31M | $281.79 | 360.61K |
| Q1 2022 | share | Decrease | -8.68% | -39.68K shares | 8.55M | $260.97 | 417.40K |
| Q4 2021 | share | Increase | +4.01% | 17.60K shares | 20.65M | $222.45 | 457.08K |
| Q3 2021 | share | Increase | +42.72% | 131.55K shares | 17.63M | $181.39 | 439.48K |
| Q2 2021 | share | Decrease | -0.93% | -2.89K shares | -4.70M | $201.63 | 307.92K |
| Q1 2021 | share | Increase | +9.32% | 26.51K shares | -402K | $214.89 | 310.81K |
| Q4 2020 | share | Increase | +3.13% | 8.64K shares | -7.82M | $236.34 | 284.30K |
| Q3 2020 | share | Decrease | -0.37% | -1.01K shares | -5.30M | $272.12 | 275.66K |
| Q2 2020 | share | Increase | +13.54% | 32.98K shares | 22.33M | $290.31 | 276.68K |
| Q1 2020 | share | Decrease | -30.18% | -105.33K shares | -18.43M | $237.95 | 243.69K |
| Q4 2019 | share | Decrease | -4.34% | -15.81K shares | 14.60M | $218.95 | 349.02K |
| Q3 2019 | share | Decrease | -4.25% | -16.19K shares | -8.06M | $169.42 | 364.84K |
| Q2 2019 | share | Decrease | -3.88% | -15.39K shares | -3.05M | $183.38 | 381.03K |
| Q1 2019 | share | Decrease | -1.31% | -5.27K shares | 6.35M | $183.95 | 396.43K |
| Q4 2018 | share | Decrease | -5.41% | -22.97K shares | -15.28M | $165.71 | 401.71K |
| Q3 2018 | share | Increase | +3.05% | 12.58K shares | 11.81M | $192.74 | 424.68K |
| Q2 2018 | share | Decrease | -3.78% | -16.20K shares | 235K | $169.96 | 412.10K |
| Q1 2018 | share | Increase | +5.07% | 20.68K shares | 8.71M | $162.98 | 428.31K |
| Q4 2017 | share | Increase | +0.51% | 2.08K shares | -573K | $149.86 | 407.62K |
| Q3 2017 | share | Increase | +11.06% | 40.39K shares | 14.60M | $152.04 | 405.54K |
| Q2 2017 | share | Increase | +7.72% | 26.17K shares | 9.99M | $128.87 | 365.15K |
| Q1 2017 | share | Increase | +9.58% | 29.62K shares | 14.27M | $109.35 | 338.97K |
| Q4 2016 | share | Decrease | -4.56% | -14.78K shares | -5.47M | $73.67 | 309.35K |
| Q3 2016 | share | Increase | +2.95% | 9.28K shares | 1.18M | $87.21 | 324.14K |
| Q2 2016 | share | Increase | +0.98% | 3.05K shares | 2.29M | $86.02 | 314.85K |
| Q1 2016 | share | Increase | +3.99% | 11.96K shares | -12.94M | $79.49 | 311.80K |